Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Rassidakis GZ, Medeiros LJ, Viviani S, Bonfante V, Nadali GP, Vassilakopoulos TP, Mesina O, Herling M, Angelopoulou MK, Giardini R, Chilosi M, Kittas C, McLaughlin P, Rodriguez MA, Romaguera J, Bonadonna G, Gianni AM, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH. Rassidakis GZ, et al. Among authors: giardini r. J Clin Oncol. 2002 Mar 1;20(5):1278-87. doi: 10.1200/JCO.2002.20.5.1278. J Clin Oncol. 2002. PMID: 11870170
BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Viviani S, Bonfante V, Nadali G, Herling M, Angelopoulou MK, Giardini R, Chilosi M, Kittas C, McDonnell TJ, Bonadonna G, Gianni AM, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH. Rassidakis GZ, et al. Among authors: giardini r. Blood. 2002 Dec 1;100(12):3935-41. doi: 10.1182/blood.V100.12.3935. Blood. 2002. PMID: 12433696 Free article.
Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Herling M, Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S, Bonfante V, Giardini R, Chilosi M, Kittas C, Gianni AM, Bonadonna G, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH. Herling M, et al. Among authors: giardini r. Clin Cancer Res. 2003 Jun;9(6):2114-20. Clin Cancer Res. 2003. PMID: 12796376
A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications.
Monfardini S, Rilke F, Valagussa P, Bajetta E, Canetta R, Buzzoni R, Giardini R, Viviani S. Monfardini S, et al. Among authors: giardini r. Eur J Cancer Clin Oncol. 1984 May;20(5):609-17. doi: 10.1016/0277-5379(84)90005-1. Eur J Cancer Clin Oncol. 1984. PMID: 6203753
ALK+ lymphoma: clinico-pathological findings and outcome.
Falini B, Pileri S, Zinzani PL, Carbone A, Zagonel V, Wolf-Peeters C, Verhoef G, Menestrina F, Todeschini G, Paulli M, Lazzarino M, Giardini R, Aiello A, Foss HD, Araujo I, Fizzotti M, Pelicci PG, Flenghi L, Martelli MF, Santucci A. Falini B, et al. Among authors: giardini r. Blood. 1999 Apr 15;93(8):2697-706. Blood. 1999. PMID: 10194450 Free article.
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.
Falini B, Bigerna B, Fizzotti M, Pulford K, Pileri SA, Delsol G, Carbone A, Paulli M, Magrini U, Menestrina F, Giardini R, Pilotti S, Mezzelani A, Ugolini B, Billi M, Pucciarini A, Pacini R, Pelicci PG, Flenghi L. Falini B, et al. Among authors: giardini r. Am J Pathol. 1998 Sep;153(3):875-86. doi: 10.1016/S0002-9440(10)65629-5. Am J Pathol. 1998. PMID: 9736036 Free PMC article.
Prognostic significance of p80 and visceral involvement in childhood CD30 anaplastic large cell lymphoma (ALCL).
Massimino M, Spreafico F, Luksch R, Giardini R. Massimino M, et al. Among authors: giardini r. Med Pediatr Oncol. 2001 Aug;37(2):97-102. doi: 10.1002/mpo.1176. Med Pediatr Oncol. 2001. PMID: 11496346
The generation of these two risk-groups was the result of a retrospective analysis of clinical risk factors for therapy failure as previously reported [Massimino M, Gasparini M, Giardini R, Ann Oncol 1995;6:915-920]. Considering the whole cohort of patients divided …
The generation of these two risk-groups was the result of a retrospective analysis of clinical risk factors for therapy failure as previousl …
Ki-1 (CD30) anaplastic large-cell lymphoma in children.
Massimino M, Gasparini M, Giardini R. Massimino M, et al. Among authors: giardini r. Ann Oncol. 1995 Nov;6(9):915-20. doi: 10.1093/oxfordjournals.annonc.a059359. Ann Oncol. 1995. PMID: 8624295 Free article.
121 results